Answers are grounded in this paper and cite their sources.
In Type 2 diabetes, C-Reactive Protein (CRP) as an inflammatory marker may be elevated. The glycoprotein Chondrex or YKL-40 is over expressed in many inflammatory conditions. The aim is to study serum hsCRP and YKL-40 in Type 2 diabetic patients in relation to cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
HA et al. (2017) studied this question.
Synapse has enriched 9 related papers. Consider them for comparative context: